a

3S Corporation is one of India’s leading stockist, exporter & wholesaler for Anti-cancer drug & Oncology medicines. We even supply & export Sex Enhancement Drugs, Cardiac & Anti Diabetic Medicines. We are a registered wholesaler & exporter for pharmaceutical products licensed by our FDA and Drug Controller in India. Our license number are 20-B/MZ6-23015 & 21-B/ MZ6-23016.

+(91)-(22)-42643060

3scorp.india@gmail.com
Andheri East, Mumbai - 400099, India.

DISCLAIMER

All the pharmaceutical products we offer are prescription drugs and should be used/taken under proper medical guidance and advice. Do not share the medicine with others, since they may be suffering from a problem that is not effectively treated by this drug. We are not an online pharmacy . We do not recommend any drug or give medical advice. We only express opinions and provide information. Whether a medication is right for you is a decision between you and the prescribing doctor. Kindly seek medical advice from a registered doctor 0r hospital/Institution before taking any of these medicines.

Monday - Saturday

10.00 - 19.00

+(91)-(22)-42643060

3scorp.india@gmail.com

Andheri East

Mumbai – 400099, India.

Topotecan Injection 2.5 & 4.5 mg

Description

Topotecan Injection 2.5 & 4.5 mg is used in metastatic carcinoma of the ovary after failure of initial or subsequent chemo therapy and in small cell lung cancer disease after failure of first line chemotherapy. It is also used in combination therapy with cisplatin for Stage IV-B, recurrent, or persistent carcinoma of the cervix which is not amenable to curative treatment with surgery and/or radiation therapy. (1)

There are many generic manufacturers in India who manufacture Topotecan Injection 2.5 & 4.5 mg including Health Biotech Limited etc.

3s corporation is Supplier,Exporter ,Wholesaler  for Topotecan Injection 2.5 & 4.5 mg in India.

Additional Information

The recommended starting dose is 1.5mg/m2 body surface area by IV infusion over 30 minutes daily for 5 consecutive days In absence of tumor progression, a minimum of four courses are recommended, as tumour response may be delayed.

Side Effects

• The most common hematologic side effects include:

neutropenia (97%), leukopenia (97%), anemia (89%), and thrombocytopenia (69%).

• The most common (>25%) non-hematologic side effects include:

nausea, alopecia, vomiting, sepsis or pyrexia/infection with neutropenia, diarrhea, constipation, fatigue, and pyrexia.

• The most common hematologic side effects include:

anemia (94%), leukopenia (91%), neutropenia (89%), and thrombocytopenia (74%).

• The most common (>25%) non-hematologic side effects include:

pain, nausea, vomiting, and infection/febrile neutropenia.

Pack Size